Key result
Percutaneous left atrial appendage occlusion devices, including Watchman, Amulet, and Lariat, are described as alternatives to anticoagulation for stroke prevention in atrial fibrillation.
This review describes percutaneous LAA occlusion techniques currently performed in the US, emphasizing the role of TEE guidance.
Answers are grounded in this paper and cite their sources.
May guide device selection in AF; leaves open comparative efficacy versus anticoagulation.
Atrial fibrillation is a very common arrhythmia whose prevalence is expected to increase significantly as the population ages. The associated stroke risk is a major cause of morbidity and mortality. Stroke prevention by anticoagulation carries its own risks, leading to the search for alternative strategies. Multiple techniques have been developed to exclude the left atrial appendage (the main source of thromboembolism in atrial fibrillation) from the circulation. Such techniques offer the hope of stroke prevention without the risks of anticoagulation. This article describes the percutaneous approaches being currently performed in the United States. Particular emphasis is placed on the use of transesophageal echocardiography to guide these procedures.
No takes yet. Share an insight, caveat, or question.
Deegan et al. (2018) conducted a review in Atrial fibrillation. Percutaneous left atrial appendage occlusion devices was evaluated. Percutaneous left atrial appendage occlusion devices, including Watchman, Amulet, and Lariat, are described as alternatives to anticoagulation for stroke prevention in atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: